Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-003568
Filing Date
2025-02-12
Accepted
2025-02-12 16:12:32
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aytu20241231c_10q.htm   iXBRL 10-Q 1568604
2 EXHIBIT 10.2 ex_768099.htm EX-10.2 49405
3 EXHIBIT 31.1 ex_751135.htm EX-31.1 13489
4 EXHIBIT 31.2 ex_751136.htm EX-31.2 13802
5 EXHIBIT 32.1 ex_751137.htm EX-32.1 8688
11 aytu20231231_10qimg001.jpg GRAPHIC 2569
  Complete submission text file 0001437749-25-003568.txt   9320376

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aytu-20241231.xsd EX-101.SCH 81598
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20241231_cal.xml EX-101.CAL 68994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20241231_def.xml EX-101.DEF 557731
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20241231_lab.xml EX-101.LAB 464888
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20241231_pre.xml EX-101.PRE 612441
103 EXTRACTED XBRL INSTANCE DOCUMENT aytu20241231c_10q_htm.xml XML 1698237
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 25614933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)